MxD awarded $15 million to boost US manufacturing’s COVID response

CARES Act funding will support supply chain resiliency, medical device deployment, and pharmaceutical industry production.
Oct. 22, 2020

MxD has been awarded $15 million in funding from the US Department of Defense via the Coronavirus Aid, Relief, and Economic Security (CARES) Act to address critical public -health and infrastructure needs and to support manufacturing as it mobilizes in response to COVID-19.

MxD’s three CARES Act-funded programs will focus on supply chain resiliency and transparency, rapid and secure medical device deployment, and pharmaceutical industry production optimization.

“We did not have a pandemic in mind as we built our expertise and strategy, but with our focus on supply chain and cybersecurity issues, MxD was made for this moment, ” said MxD CEO Chandra Brown. “Our programs support both immediate and long-term efforts to address critical shortages, develop capacity for response among manufacturers, and secure the industry during these unprecedented times.”

Sign up for Smart Industry Newsletters
Get the latest news and updates